Genis is an innovative Icelandic biotechnology company, pioneering the development of therapeutic chitin derivatives.

Our goal is to address an unmet need by providing effective therapeutic solutions across a number of inflammatory diseases, including lung diseases such as asthma and COPD, type II diabetes, rheumatoid arthritis and endometriosis.

We are also developing a number of orthobiologic applications that are based on the regenerative tissue and osteogenic activities and anti-bacterial properties of chitin derivatives.